UK steps towards health protection reform:
This article was originally published in Clinica
Executive Summary
The UK has moved a step closer to the inauguration of the new national Health Protection Agency (HPA), with the appointment of Pat Troop as chief executive. The HPA, which becomes operational on April 1 2003, brings together the functions of most of the Public Health Laboratory Service, the Centre for Applied Microbiology and Research, the National Focus for Chemical Incidents and other health protection consultants and regional staff. It will be responsible for regulating biological, chemical and radiological hazards, as well as infectious disease control and health emergency planning. Subject to legislation, the HPA may become a non-departmental public body, taking on the functions of the National Radiological Protection Board. Dr Troop is currently deputy chief medical officer of the Department of Health.
You may also be interested in...
EU Consults On What Constitutes Personal & Commercially Confidential Data In Marketing Applications
Based on their experience with dealing with requests for access to documents over the past 12 years, EU regulators have proposed updating their guideline that provides for a harmonized approach to protecting personal data and business secrets in marketing authorization applications.
Industry & Regulators To Align Advice on COVID-19 Vaccine Updates
A multi-stakeholder workshop looked at the data needed to support updates to vaccine composition and the time required by manufacturers to update their vaccines, change their manufacturing processes and prepare approval applications.
Sanofi Skates To Where The Puck Is With Immunology
The French drugmaker has not abandoned oncology but has made it very clear that immunology and inflammation is the priority for its R&D euros.